Welcome to the official website of the Ethypharm Group. This website is regulated by the Code of Best Practices of the International Federation of Pharmaceutical Manufacturers. Some information on this site may not be in conformity with French regulations on advertising. By continuing your navigation, you accept this website's use of cookies.



Ethypharm acquired Martindale Pharma creating its position as a leading UK-based specialty pharmaceutical company providing value adding pharmaceutical products to over 80 countries around the world. Specializing in the fields of Opioid Addiction, Critical Care and Pain, Ethypharm UK is recognised as a key partner to the NHS and the private hospital sector with a vast range of quality products.


Ethypharm acquired DB Ashbourne, which became the UK subsidiary of the Group. Ethypharm UK started to market and supply its products directly including Morphine Sulfate prolonged release under the name of Zomorph®.
DB Ashbourne LTD establishes in the UK as a branded pharmaceutical business, commercial operations started in 2009 with the marketing and supply of a range of prescription only medicines to the UK market and generating significant savings for the National Health Service.
Ethypharm acquired Prographarm Laboratoire in France.
Ethypharm established and became rapidly a major player in the field of Drug Delivery Systems in France.
Martindale Pharma was launched as a trading company for Macarthys Laboratories Ltd.
Savory and Moore Ltd was acquired by Macarthys Laboratories Ltd.
William Martindale was acquired by Savory & Moore Ltd.
William Martindale acquired a pharmacy from Hopkins & Williams.
James Macarthy founded a retail pharmacy in Romford.

Ethypharm UK - part of the Ethypharm Group

By joining forces with Martindale Pharma, Ethypharm reinforced its presence in the UK and the combined group now benefits from a broader geographical reach. This allows the Group to commercialise its products into many markets helping patients around the world get access to better medicines.

The consolidation of Martindale Pharm with Ethypharm UK has enabled stronger manufacturing capabilities to be developed including solid dose, injectables and oral liquids.

By clicking on this link, you agree to leave our website.
Are you sure?

NO     YES